Anales RANF

Nannocannabinoids for brain tumor drug delivery @Real Academia Nacional de Farmacia. Spain 215 Figure S2: Quantitative analysis of the in vivo biodistribution of DiD-labeled LNCs in healthy mice expressed as percentage of the injected dose per gram of organ: (a) blood, (b) lungs, (c) kidneys, (d) heart, (e) spleen and (f) liver. The colours and fill patterns of the LNC formulations correspond to those of figure 2. *: p<0.05, **: p<0.01, ***: p<0.001.